General guidance on management of rheumatology patients during COVID-19 is available from the British Society for Rheumatology. This page gives advice on drug monitoring in…
Chronic kidney disease impacts upon prescribing for some disease modifying anti-rheumatic drugs. Methotrexate is usually hospital-initiated but rheumatology and dermatology patients will be monitored by…
This updated Medicines Q&A is a quick reference summary to different types of enteral feeding tubes, in relation to medication issues. Not all enteral feeding…
This document is intended to support local discussions on how to monitor commonly prescribed high risk medicines in primary care. Comments have been included as…
This UKMi Product Safety assessment on methotrexate pre-filled devices identifies relevant differences between these products and highlights any potential safety concerns in case of intentional or unintentional…
This Medicines Q&A reviews the evidence that alcohol increases risk of methotrexate-induced liver toxicity, and advises on safe levels of alcohol intake by patients taking…
Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Aminosalicylates for chronic bowel disorders Mesalazine…
The evidence for an interaction between methotrexate and penicillins is limited to case reports and animal studies. So far, there is no conclusive evidence that…
There is no definitive answer regarding the optimal dose of folic acid for patients with rheumatoid arthritis who are being treated with methotrexate. It is…